Skip to content
naulon

Not checkedNot checked for notices yet.

The predictive value of serum bilirubin in the post-liver transplant de novo malignancy: A data mining approach

Nasim Nosoudi, Amir Zadeh, Hunter White and 3 more

Healthcare Analytics · 2022

doi:10.1016/j.health.2022.100094 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Post-transplantation de novo malignancy in immunosuppressed organ recipients has become a major source of death, making early cancer surveillance through diagnosis and detection important in drastically improving survival rates. The focus of this work is on predicting de novo malignancy after liver transplantation using machine learning. Patients were chosen as those having developed malignancy after liver transplantation, with no history of cancer prior to transplantation, with donors being cancer-free as well. We analyzed a large volume of patients with post-transplant malignancy from the US Organ Procurement and Transplantation Network (OPTN). Several popular data mining methods were employed to characterize de novo malignancy after liver transplantation. Recipient’s bilirubin, creatinine, weight, gender, number of days in wait on the transplant list, Epstein Barr Virus (EBV), International normalized ratio (INR), and ascites were found to be among the most important factors affecting post-liver-transplantation de novo malignancy occurrence.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.